In the SURMOUNT-1 trial, tirzepatide treatment resulted in favorable changes in body composition, with fat mass reduction approximately threefold greater than lean mass reduction
The cell biology of bone metabolism
Your provider reviews health history, medications, and goals before recommending any protocol
Moreover, our findings indicate that the endocrine pancreas is also an important source of GLP-1 targeted by DPP-4 inhibitors to confer better glucose tolerance
JeanGilles emphasizes that while the medication begins working in your body soon after injection, your most noticeable effects develop gradually with consistent weekly dosing
Its not yet known whether GLP-1s can flip this switch, but there is a medical precedent for this, Schwartz says